Quantcast

Latest Biomarker Stories

2014-09-19 23:08:36

SNBL Clinical Pharmacology Center, Inc. (SNBL CPC), a 96-bed clinical pharmacology research unit specializing in complex early-phase trials, announced today the successful completion of a validation study of the NeuroCart. The study validated the NeuroCart as an effective tool for detection of benzodiazepine-evoked pharmacodynamic CNS effects. Baltimore, MD (PRWEB) September 19, 2014 SNBL Clinical Pharmacology Center, Inc. (SNBL CPC), a 96-bed clinical pharmacology research unit...

2014-09-19 23:04:17

GIA announces the release of a comprehensive global report on Immunoassay Systems. Global market for Immunoassay Systems is projected to reach US$17.9 billion by 2020, driven by aging population, rise in chronic & infectious diseases, development of novel biomarkers, robust demand for non-invasive diagnostic tools, and improved access to healthcare & testing services in developing countries. San Jose, California (PRWEB) September 19, 2014 Follow us on LinkedIn – Immunoassays are...

2014-09-19 04:21:35

DUBLIN, September 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular) has announced the addition of the "Global Molecular Cytogenetics Market 2014-2018" [http://www.researchandmarkets.com/research/qqjrnh/global_molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular Cytogenetics involves the study of chromosomes using molecular biology to understand...

2014-09-18 08:29:26

-ATHENA to Shed Light on Rare, Life-Threatening Kidney Disease - LA JOLLA, Calif., Sept. 18, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today it has initiated its ATHENA natural history of disease study in patients with Alport syndrome, a life-threatening genetic kidney disease with no approved therapy. The ATHENA study is designed to...

2014-09-17 12:27:05

New multi-year grant furthers non-profit organization's work to accelerate the drug development process TUCSON, Ariz., Sept. 17, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) has awarded the organization $2.1 million in first year funding of a five-year grant with the potential of $10.5 million over the five years. This is the second five-year grant that C-Path has received from the FDA under the...

2014-09-17 08:29:26

- Phase 2 Clinical Results Show Positive Trends in Slowing Advancement of Disease - PALO ALTO, Calif., Sept. 17, 2014 /PRNewswire/ -- Neuraltus Pharmaceuticals, Inc. announced today that promising efficacy results of the Company's Phase 2 clinical program of NP001 for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) are being highlighted today in an oral presentation at the inaugural Summit of the ALS Research Group, being held in Bloomington,...

2014-09-17 08:28:48

IBM Technical Computing & Software Defined Storage Technology Manages Growing Scale and Diversity of Molecular Profiling Data in Cancer Care ARMONK, N.Y., Sept. 17 2014 /PRNewswire/ -- IBM (NYSE: IBM) today announced that Caris Life Sciences is using IBM technical computing and storage technology to accelerate the company's molecular profiling services for cancer patients. These services deliver critically important information to help oncologists develop tailored therapeutic plans...

2014-09-15 23:01:51

Studies conducted by the non-profit Institute of BioAcoustic Biology, located in Albany, Ohio, USA, have consistently demonstrated that math can be much more than a measurement tool; math, as a frequency matrix, can serve as the template to perceive and manage health and wellness. http://www.JournalofBioAcousticBiology.org Albany, Ohio (PRWEB) September 15, 2014 In order to provide predictability and safety, the concepts of math and medicine often act conjointly to quantify, define and...

2014-09-09 08:30:45

WASHINGTON, Sept. 9, 2014 /PRNewswire/ -- Gentag, Inc. is pleased to announce that it has been granted a new, additional allowance for its patents in Europe. This allowance, granted by the European Patent Office, further enhances the company's already significant intellectual property holdings of near field communication (NFC) mobile phone sensor technologies and complements its disposable wearable NFC sensor patent portfolio. The new patent covers quantitative diagnostic tests that...

2014-09-03 23:12:42

The webinar, in partnership with Asuragen, will be presented live September 10, 2014 1:00pm Eastern Time (PRWEB) September 03, 2014 LabRoots announces a new educational webinar for the NGS community. The webinar, titled “NGS Lessons in Translational Diagnostics: Mining and Migrating Robust Cancer Biomarkers to Unified DNA and RNA NGS Panels,” will be airing live September 10, 2014 1:00pm Eastern Time. In this webinar, a comprehensive approach for NGS-based biomarker discovery will...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related